299 related articles for article (PubMed ID: 3392730)
1. A study of the evolution of specific and non-specific immune complexes in acute hepatitis B and chronic hepatitis.
Leyva A; Bernal MC; Piedrola G; Maroto MC
J Med Microbiol; 1988 Jul; 26(3):237-9. PubMed ID: 3392730
[TBL] [Abstract][Full Text] [Related]
2. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
Perisić-Savić M; Nastić-Mirić D
Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
[No Abstract] [Full Text] [Related]
3. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
[No Abstract] [Full Text] [Related]
4. [Occurrence of HBV serological markers in patients with chronic hepatitis].
Cichoz-Lach H; Słomka M; Daniluk J; Celiński K; Pokora J
Pol Arch Med Wewn; 1992 Oct; 88(4):244-9. PubMed ID: 1488325
[No Abstract] [Full Text] [Related]
5. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
[No Abstract] [Full Text] [Related]
6. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
Chang ML; Chou CT; Lee CF; Chang DM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
[TBL] [Abstract][Full Text] [Related]
7. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis.
Babeş VT; Tănase M; Cepănaru S; Cepănaru R
Virologie; 1981; 32(2):93-8. PubMed ID: 6787796
[TBL] [Abstract][Full Text] [Related]
8. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
[No Abstract] [Full Text] [Related]
9. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
[No Abstract] [Full Text] [Related]
10. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
Lyra LG
Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM
Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing between acute and symptomatic chronic hepatitis B virus infection.
Maruyama T; Schödel F; Iino S; Koike K; Yasuda K; Peterson D; Milich DR
Gastroenterology; 1994 Apr; 106(4):1006-15. PubMed ID: 7511551
[TBL] [Abstract][Full Text] [Related]
13. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative and qualitative findings of hepatitis B virus-associated antigens, receptors and antibodies in the course of the acute phase of hepatitis B infection].
Gröticke JW; Gerken G; Steinmann J; Arnold W
Z Gastroenterol; 1988 Jul; 26(7):363-73. PubMed ID: 2851892
[TBL] [Abstract][Full Text] [Related]
15. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
Babeş VT; Cepănaru S; Cepănaru R; Tănase M
Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
[TBL] [Abstract][Full Text] [Related]
16. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
Hasçelik G; Günalp A
Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
[TBL] [Abstract][Full Text] [Related]
17. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
[TBL] [Abstract][Full Text] [Related]
18. Immunology of hepatitis B virus infections.
Heermann KH; Gerlich WH
Rheumatol Int; 1989; 9(3-5):167-73. PubMed ID: 2692126
[TBL] [Abstract][Full Text] [Related]
19. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis B: serological strategy and epidemiological aspects].
Penna R; Rabagliati AM
G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
